Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its participation at the Piper Sandler 37th Annual Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback